Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. - Wikidata - awgldk - TriplyDB

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

http://www.wikidata.org/entity/Q32010564

about

Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.Potential uses of probiotics in clinical practice Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis.Do probiotics have a therapeutic role in gastroenterology?Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori.Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?Role of probiotics in patients with Helicobacter pylori infection.Probiotics and non-intestinal infectious conditions.Probiotics and intestinal health effects: a clinical perspective.Review article: the treatment of refractory Helicobacter pylori infection.H. pylori and its modulation of gastrointestinal microbiota.A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice.Improved Helicobacter pylori Eradication Rate of Tailored Triple Therapy by Adding Lactobacillus delbrueckii and Streptococcus thermophilus in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial.Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges.Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.Probiotics and gastrointestinal diseases.Live bacterial cells as orally delivered therapeutics.Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and helicobacter-induced gastritis.Living drugs for gastrointestinal diseases: the case for probiotics.Non-digestible oligosaccharides with prebiotic properties.Intestinal bacteria and ageing.Probiotics in clinical practice: an overview.Long-Term Use of Probiotic-Containing Yogurts Is a Safe Way to Prevent Helicobacter pylori: Based on a Mongolian Gerbil's Model.Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial.Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics.Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents Do probiotics offer opportunities to manipulate the periodontal oral microbiota?Probiotic fermentation of plant based products: possibilities and opportunities.Helicobacter pylori and other gastric bacteria.Indications for the use of probiotics in gastrointestinal diseases.Efficacy of fermented milk and whey proteins in Helicobacter pylori eradication: a review.Emerging Role of Probiotics in the Management of Helicobacter pylori Infection: Histopathologic Perspectives.Anti-Helicobacter pylori activity of non-living, heat-killed form of lactobacilli including Lactobacillus johnsonii No.1088.Lactic acid bacteria strains exert immunostimulatory effect on H. pylori-induced dendritic cells.Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1.Nutritional advantages of probiotics and prebiotics.Lactobacillus reuteri in the treatment of Helicobacter pylori infection.Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.

P2860

Q24535026-6627648E-6A54-4B64-AA5D-8F045C8964AB Q24681377-AA8A9CAD-0B94-410C-B0A1-442EB89AE15B Q26991504-AFA99385-CE88-40C8-967E-0CEFA8BB6ECA Q28206590-D1A41050-542D-4FF3-9131-64D0AB73781F Q33430413-BBD93085-BED3-4A6B-8DE8-D616F6730674 Q33869477-3D558BB0-0D78-4556-9DCA-558472BD254D Q34520547-27BCE775-FDD1-42AC-9658-F3F5A7F904F9 Q34566465-E6F7672A-D80A-4FF2-A9DD-038E83094640 Q34711908-75BBBC38-BDCD-40F5-8D32-16AEE41DD06B Q34820549-3C1D4F17-884C-4744-8228-C4C3BDBDF603 Q34820582-AD305C29-E82B-47DD-9801-02B1BA12AA65 Q35145092-94E5C321-3ABF-4A69-A4B1-203A71FB75A2 Q35549642-C87318C6-CF81-4A44-8DE3-36D7E27FC634 Q35577427-3995AA1E-D926-444A-AA70-8EEC8B4B98A0 Q35763686-E4609037-D9A0-4588-B651-EA78DF0B37CA Q35800667-31DB9F81-577B-462B-B14A-41FC20CCF10A Q35890738-57DA3977-9C16-42E1-8C03-D56D8FD78F30 Q35987864-A348DE98-1356-44A5-BA3C-C971D0652F87 Q36273383-9C9041C4-54B5-448E-88C0-174FD92363BD Q36438490-F5DCCE77-18E2-4904-9EFE-AE4BCE5C56DC Q36478112-45613600-95BF-48CF-8C27-20F425BAAA2E Q36545386-CDEB400F-1030-4316-BDAE-0A74603BEFE4 Q36797288-60A7E20F-11B4-4838-9E54-95FAB0BB7A52 Q37071265-1A1352D7-8B87-4E47-97FC-B6AE7539455C Q37375658-D48758DF-3234-402E-9582-7F09A3A4D538 Q37410679-AE85CA93-4F3B-43A1-82DF-3281B113922C Q37682514-0C5A9B07-C0DF-49AE-9401-204775068030 Q37712802-F60C918B-E1CC-4E03-AA2E-3A4553C63D5D Q37842653-8F6DAF2C-6DC7-48D4-B713-5F1A7B2FC3E5 Q37953487-C1A9A02E-5E3B-488A-8638-C118D40D9686 Q37969590-0C7BDB68-647E-4AC3-80AC-E164E6AFF7FD Q37969593-80EFB506-126F-4C7E-895F-AE69DA20C31D Q38191569-3FC082A5-CAA3-4D62-ADF2-5EAC2E2CE67E Q38495648-09ADBA88-8C67-4A50-97C1-CDD42CC9A082 Q40212568-BB8C98C1-01A3-4D23-8ECF-340FEE1C8C70 Q42002775-FAB87026-6AB6-4F02-9A9D-E6FBB1773188 Q43332026-5A06257A-9BA2-4EC3-B37E-BAC33EE89803 Q44044223-5CAB635B-B437-4D32-B5F5-B77A440CDBE1 Q44119720-556BD0EE-1772-40FE-8779-C708C5AAC64F Q46236620-DDD20DC8-9A33-4FD0-8F36-35C7B5581172

P2860

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

http://www.wikidata.org/entity/Q32010564

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

@ast

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

@en

type

label

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

@ast

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

@en

prefLabel

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

@ast

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

@en

P1433

Q32010564-D1F414FD-3118-42E3-A5F7-1666E488CBC8

P1476

Q32010564-52D6E4F0-6419-4B16-BBE3-BF7E6023F027

P2093

Q32010564-0408CA70-70D6-4241-B9C7-C94420BC0E4D

Q32010564-0C85F8A1-885C-4D4D-B99B-6586AAED33F3

Q32010564-12EE9691-96D5-4177-83EB-D8B0DCAA5BFF

Q32010564-2474E4E0-DE98-41A7-90C7-70B53DD4C61D

Q32010564-2CB7E49E-60F2-4594-BFB3-8C78A835D398

Q32010564-3B3D4AB1-557F-4D14-B8EE-192FE00120A4

Q32010564-42219A10-8C89-4319-B076-BC3A38D825B1

Q32010564-8E103C55-493D-4EC0-A344-642E7A8040DC

Q32010564-D2FFDB97-4D81-46A6-97D8-84E08AFC2CAD

Q32010564-E830CDF1-0E26-4E54-894B-E12FEB98E561

P304

Q32010564-A952E6F7-FDF9-4EE0-A64F-3DF58EDA9808

P31

Q32010564-5523B503-932D-40A9-AF7C-940C7E015F36

P356

Q32010564-CA166E19-F443-49CA-BF1D-E4C2E83D09B0

P433

Q32010564-1DFAF5C8-83F8-4083-B488-DA17F7350268

P478

Q32010564-EF01FA9D-C4AF-40F7-9BE3-4AEE1C6BBA7B

P577

Q32010564-E27860B6-BB48-4DC7-AD9B-DAD7CAB498E2

P698

Q32010564-F4856463-F915-4DE7-8471-9A234173D584

P921

Q32010564-E491996E-069C-44DF-BD54-F2863DBD584F

P356

00042737-200101000-00005

P1433

European Journal of Gastroenterology and Hepatology

P1476

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

@en

P2093

Bauerfeind P

http://www.w3.org/2001/XMLSchema#string

Blum AL

http://www.w3.org/2001/XMLSchema#string

Brassart D

http://www.w3.org/2001/XMLSchema#string

Corthésy-Theulaz I

http://www.w3.org/2001/XMLSchema#string

Felley CP

http://www.w3.org/2001/XMLSchema#string

Kaufmann M

http://www.w3.org/2001/XMLSchema#string

Michetti P

http://www.w3.org/2001/XMLSchema#string

Pfeifer A

http://www.w3.org/2001/XMLSchema#string

Rivero JL

http://www.w3.org/2001/XMLSchema#string

Sipponen P

http://www.w3.org/2001/XMLSchema#string

P304

25-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00042737-200101000-00005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11204805

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori